Appendix C

Statement of Task

An ad hoc planning committee will plan and conduct a public workshop that will examine methods for accelerating the approval and adoption of genomic diagnostic tests. The workshop will feature presentations and discussions from an array of stakeholders which may include providers, payers, guideline developers, diagnostic device developers, product reviewers, patients, and regulators. The goal of the workshop will be to advance discussions among policymakers and the broader public on the current challenges which are limiting the development and utilization of diagnostic tests, such as commercial considerations, regulatory policy, and evidence of clinical utility. The planning committee will develop the workshop agenda, select and invite speakers and discussants, and moderate the discussions. An individually-authored summary of the workshop will be prepared by a designated rapporteur in accordance with institutional policy and procedures.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 77
Appendix C Statement of Task An ad hoc planning committee will plan and conduct a public work- shop that will examine methods for accelerating the approval and adoption of genomic diagnostic tests. The workshop will feature presentations and discussions from an array of stakeholders which may include providers, payers, guideline developers, diagnostic device developers, product review- ers, patients, and regulators. The goal of the workshop will be to advance discussions among policymakers and the broader public on the current challenges which are limiting the development and utilization of diagnostic tests, such as commercial considerations, regulatory policy, and evidence of clinical utility. The planning committee will develop the workshop agenda, select and invite speakers and discussants, and moderate the discussions. An individually-authored summary of the workshop will be prepared by a des- ignated rapporteur in accordance with institutional policy and procedures. 77

OCR for page 77